| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_283eeb6524d057ba94318da7cb6b78fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L19-00 |
| filingDate |
2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f695bd8c90f110d2f28f285deafd61a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62fc0ad5bfc216cc178e41b935baa2bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49d8453551254253efd2f3bfff2f9869 |
| publicationDate |
2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110122580-A |
| titleOfInvention |
Use of Ginsenosides for the Prevention and Treatment of Autoimmune Diseases |
| abstract |
The present invention is a food, medicine and cosmetic composition for the prevention and treatment of autoimmune diseases comprising at least one compound selected from the group consisting of floralginsenoside J and ginsenoside I as an active ingredient. It is about. Floringinsenoside J or ginsenoside I according to the present invention is excellent in inhibiting interleukin-12 production and is useful for the treatment of autoimmune diseases caused by interleukin-12. Can be utilized. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102766184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107252132-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106573009-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106573009-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107252132-A |
| priorityDate |
2010-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |